144 results
Page 3 of 8
424B5
xo6o2xmsi2hkqp8l 3d
27 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
h07q4van6qr1eh dhv2f
27 Jun 14
Entry into a Material Definitive Agreement
12:00am
424B5
3hqx6no9hjz3
24 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
5lb7rx fpkw
22 Nov 13
Entry into a Material Definitive Agreement
12:00am
424B5
bm4p1qcm 1a
21 Nov 13
Prospectus supplement for primary offering
12:00am
424B5
c5r5baxl zimwtpci8q
19 Nov 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
ejfc8k3dkgd3kme
18 Dec 12
A.P. Pharma Makes Key Appointments in Preparation of Potential FDA Approval of Lead Product Candidate, APF530
12:00am
8-K
EX-99.1
zv941du
14 Dec 12
A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer
12:00am
8-K
EX-10.1
aut9pfbk
25 Jul 12
A.P. Pharma to Raise $53.6 Million in Common Stock Offering
12:00am
CORRESP
fcxgba
27 Jul 11
Correspondence with SEC
12:00am